Trials / Completed
CompletedNCT02213731
Cryoballoon Ablation for Early Persistent Atrial Fibrillation (Cryo4 Persistent AF)
Cryoballoon Ablation for Early Persistent Atrial Fibrillation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 130 (actual)
- Sponsor
- Medtronic Cardiac Ablation Solutions · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this clinical study is to assess the single procedure outcomes of using cryoballoon ablation without additional empirical lesions and/or complex fractionated electrogram (CFE) ablations for patients with early persistent atrial fibrillation (\<1 year from first diagnosis of persistent AF).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Holter monitoring | Subjects will wear holter monitors at baseline, 6 months and 12 months. |
Timeline
- Start date
- 2014-12-08
- Primary completion
- 2017-06-22
- Completion
- 2017-09-12
- First posted
- 2014-08-11
- Last updated
- 2025-02-13
Locations
14 sites across 3 countries: France, Germany, Greece
Source: ClinicalTrials.gov record NCT02213731. Inclusion in this directory is not an endorsement.